Hoth Therapeutics, Inc. (HOTH) Financials

HOTH Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 12.1 million 1.6 million
2023-06-30 11.9 million 2.0 million
2023-03-31 13.5 million 1.6 million
2022-12-31 6.8 million 1.6 million

HOTH Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -1.6 million 190265
2023-06-30 -1.4 million 9748
2023-03-31 -2.3 million 10630
2022-12-31 -2.6 million 15468

HOTH Net Income

No data available :(

HOTH Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 11.9 million - -
2023-06-30 11.6 million - -
2023-03-31 13.2 million - -
2022-12-31 6.6 million - -

HOTH Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 3.5 million
2023-06-30 3.3 million
2023-03-31 2.5 million
2022-12-31 1.2 million

HOTH Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 974374 1.1 million -
2023-06-30 - 652202 1.1 million -
2023-03-31 - 938878 1.3 million -
2022-12-31 7500 1.5 million 2.0 million -

HOTH Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 6752
2023-06-30 - 7897
2023-03-31 - 15120
2022-12-31 - 66834

HOTH

Price: $1.23

52 week price:
0.99
4.30

Earnings Per Share: -2.30 USD

P/E Ratio: -0.29

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 7144

Market Capitalization: 6.0 million

Links: